Reagent | PEIpro®-HQ |
---|---|
Moleculedelivered | DNA |
Applications | Productionofclinicalgradevirusesandproteins |
Celltypes | AdherentorsUSPensionHEK-293andHEK-293Tcellsandderivativesgrowninsyntheticserum-freemedium |
Numberoftransfections | 1LiterofPEIpro®-HQissufficienttotransfectonaverage500Litersofcellculture |
Storage | 4°C,foratleast2years |
Providedwith | CertificateofAnalysis |
Advancedtherapymedicinalproducts(ATMPs)includinggenetherapyandcelltherapymedicineshaveemergedaspromisingtreatmentsforvariousdiseases.ThesetherapiesinvolvetheintroductionoftherapeuticDNAintopatient’sbodyorpatient’scells.Thisprocessisoftenaccomplishedbytheuseofviralvectors.RawmaterialsusedforthemanufacturingoftheseviralvectorsneedtobemanufacturedaccordingtoarobustandreproducIBLeprocess,withappropriateQualityControls.
PEIpro®-HQisafullysyntheticreagentfreeofanyanimal-origincomponents.PEIpro®-HQismanufacturedandformulatedusingawell-establishedandcontrolledmanufacturingprocess(Fig.1),allowingthereproduciblesupplyofremarkablyhighqualityproductmeetingverystringentreleasespecifications.
EachlotofPEIpro®-HQisprovidedwithaBatchProductionDocumentationthatcontainsacomprehensivesummaryofthemanufacturingprocessandthequalitycontrols,whichmakesPEIpro®-HQperfectlysuitableforuseasaqualifiedrawmaterialfortheproductionofclinicalbatchesofvirusesandproteinsinGMPprocesses.
PEIpro®-HQisanoptimizedandselectedPEI,trulydeacylated,withanextremelylowpolymerchainlengthvariationandformulatedat1mg/mlinwater.
Recently,thereisanincreaseinregulatoryscrutinyforreagentsusedasrawmaterialintheproductionofvirusesforearly-phaseclinicaltrials.Alongwiththerecentincreaseinbiopharmaceuticalfundingingenetherapy,itisnowmandatorytomeethigherlevelsofqualitycomplianceatearlierstagesofclinicaldevelopment.WithitsextensiveQualityControlsPEIpro®-HQfullyanswerstheseneeds.
ThequalityofPEIpro®-HQiscontinuouslyassessedduringthemanufacturingprocesswithsuitablecontroltesting.AnextensivenumberofQualityControlsareperformedonboththebulkmaterialandtheformulatedproducttoassessidentity,potency,safetyandpurityofPEIpro®-HQ(Table1).
Indeed,PEIpro®-HQistestedtoensurecompletesterility,absenceofmycoplasmaandverylowlevelofbacterialendotoxinsfollowingpharmacopoeiastandards.Impurityprofile,residualorganicsolventandheavymetalcontentarealsotestedtoassessthepurityofthereagent.Moreover,astandardizedtransfectionassayisperformedwithasuspensionHEK-293celllineinserum-freemediumtoensurethereliABIlityandreproducibilityofthetransfectionefficiencyunderconditionsthataresuitableforvirusproduction.
PEIpro®-HQisreleasedwithaCertificateofAnalysisincludingtheresultsoftheQualityControls.AfulllistofQCsisavailableuponrequest(ContacttheTechnicalSupport).
PEIpro®-HQisalsosuppliedwithaCertificateofOriginconfirmingtheabsenceofcomponentsofanimaloriginandaNon-HazardousProductStatement.
PEIpro®-HQcombinesanexceptionalqualitygradewithrobusttransfectionefficiency.PEIpro-HQ®iscurrentlyusedfortheproductionoflargequantitiesofviralvectors,includingAdenovirus,AdenoAssociatedVirus(AAV)andlentivirus.PEIpro®-HQissuitableforuseinmammaliancellssuchasHEK-293andHEK-293Tgrownadherentlyorinsuspensioninbothserumcontainingmediaorsyntheticchemicallydefinedmedia.PEIpro®-HQcanbeusedinalltypesofcellculturevessels,singleusedbioreactors(SUB),WAVEbagsandfixedbedbioreactorssuchasiCELLIS®.FollowingPEIpro®-HQmediatedtransienttransfection,lentivirustitersroutinelyreachupto10^14VG/ml.
Readmore…
SouthernBiotech/Goat Anti-Human Lambda-Alexa Fluor® 555/2070-32/1.0 mg
vectorlabs/Biotinylated Aleuria Aurantia Lectin (AAL)/B-1395/1 mg
vectorlabs/VECTASTAIN® Elite® ABC-HRP Kit (Peroxidase, Mouse IgG)/PK-6102/1 kit
vectorlabs/VECTASTAIN® Elite® ABC-HRP Kit (Peroxidase, Universal)/PK-6200/1 kit
vectorlabs/Unconjugated Musa Paradisiaca (Banana) Lectin (BanLec)/L-1410/5 mg
GiottoBiotech/Calmodulin N60D/5 mg/G02CLM60cn